Mar 30, 2026Oral HealthOmega-3, Gum Disease, and Diabetes: What Chemerin Can Tell UsCan omega-3 supplements alongside periodontal care lower chemerin in type 2 diabetes? A close look at the small trial, ozone, and polyphenol evidence.periodontitisomega-3type 2 diabeteschemerinRead article →
Mar 30, 2026Cardiovascular HealthMorning Blood Pressure Surge: Does Exercise Timing Help?Morning versus evening HIIT did not change the morning blood pressure surge in a small trial. Training type, chronotype, and diet may matter more.morning blood pressure surgembpsexercise timingcardiovascular riskRead article →
Mar 30, 2026Cardiovascular HealthBlood Pressure Apps: Useful Tools, Unproven TreatmentDo blood pressure apps work? Trials find small systolic drops, but clinician support rather than software alone may explain the benefit and limit long-term value.blood pressurehypertensiondigital healthsmartphone appsRead article →
Mar 29, 2026Cardiometabolic DrugsTirzepatide Safety in Heart-Risk Diabetes: What We KnowTirzepatide can improve weight and glucose control, but what do cardiovascular-risk trials show about nausea, serious harm, and mortality?tirzepatideglp-1 agonisttype 2 diabetescardiovascular riskRead article →
Mar 27, 2026Sedentary BehaviorWork Sitting May Matter More Than Leisure SittingWorkplace sitting may predict higher healthcare costs and mortality apart from exercise. What the evidence says about desk time, breaks, and risk.sedentary behavioroccupational healthcardiovascular risksitting timeRead article →
Mar 26, 2026NutritionPrediabetes Remission, Anthocyanins, and Heart RiskPrediabetes remission tracks with lower cardiovascular risk for decades. What anthocyanin and raspberry-prebiotic trials can and cannot show.prediabetesglucose toleranceanthocyaninsinsulin sensitivityRead article →